Global Orexin Receptor Antagonists Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Orexin Receptor Antagonists market size was valued at US$ 5216 million in 2024 and is forecast to a readjusted size of USD 7835 million by 2031 with a CAGR of 6.1% during review period.

Orexin receptor antagonists are the type of therapeutics used in the treatment of sleep disorders, characterized by difficulties or problems with sleep onset. It either bind or inhibits the action of orexin receptor. Orexin plays a vital role in the sleep–wake cycle through a complex interplay between the monoaminergic/cholinergic (wake-promoting) and gamma-aminobutyric acidergic (sleep-promoting) neuronal systems.

Increased prevalence of various sleep disorders such as insomnia and parasomnias, along with rising incidence of depression and other distressing disorders are major factors driving insomnia. Expanding the Global Insomnia Market. Sleep disturbance is a common symptom of depression. For example, according to the World Health Organization (WHO), approximately 280 million people worldwide suffer from depression. Hence, the surge in the prevalence of psychotic depression across the world has led to the expansion of the insomnia market. In addition, long-term use of a drug to treat a chronic condition may cause certain adverse effects, some of which are thought to impair a patient"s ability to get a good night"s sleep. This means that the expansion of the market is driven by the increasing prevalence of chronic diseases such as cancer.

This report is a detailed and comprehensive analysis for global Orexin Receptor Antagonists market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Orexin Receptor Antagonists market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Orexin Receptor Antagonists market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Orexin Receptor Antagonists market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Orexin Receptor Antagonists market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Orexin Receptor Antagonists

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Orexin Receptor Antagonists market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eisai Co., Ltd, Sun Pharmaceutical Industries Ltd, Novartis AG, Endo Pharmaceuticals plc, Mylan NV, Cereve Inc., Teva Pharmaceutical Industries Ltd, Amneal Pharmaceuticals Inc, Merck & Co., Sanofi, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Orexin Receptor Antagonists market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Oral

Parenteral

Market segment by Application

Insomnia

Anxious

Other

Major players covered

Eisai Co., Ltd

Sun Pharmaceutical Industries Ltd

Novartis AG

Endo Pharmaceuticals plc

Mylan NV

Cereve Inc.

Teva Pharmaceutical Industries Ltd

Amneal Pharmaceuticals Inc

Merck & Co.

Sanofi

Currax Pharmaceuticals LLC

Pfizer Inc.

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Orexin Receptor Antagonists product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Orexin Receptor Antagonists, with price, sales quantity, revenue, and global market share of Orexin Receptor Antagonists from 2020 to 2025.

Chapter 3, the Orexin Receptor Antagonists competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Orexin Receptor Antagonists breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Orexin Receptor Antagonists market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Orexin Receptor Antagonists.

Chapter 14 and 15, to describe Orexin Receptor Antagonists sales channel, distributors, customers, research findings and conclusion.